Literature DB >> 18632038

Diabetes prevalence and quality of diabetes care among Lebanese or Turkish immigrants compared to a native Danish population.

Jette Kolding Kristensen1, Jens Friis Bak, Inge Wittrup, Torsten Lauritzen.   

Abstract

OBJECTIVES: To describe Type 2 diabetes prevalence and care among Turkish (T) and Lebanese (L) immigrants as compared to native Danes (DK) in the county of Aarhus.
METHOD: Data from The National Health Service Registry, The Regional Laboratory Database and The Danish National Hospital Registry were collected from 2000 through 2003 to identify and describe known diabetes in a background population of 244.426 citizens in the age group of 40-70 years living in the County of Aarhus.
RESULTS: The age-standardised prevalence of Type 2 diabetes was 3.6% (DK), 18.9% (L) and 19.8% (T). In 2003, HbA1c was measured at least once in 84% (DK), 87% (L) and 83% (T) of the patients. In 2003, 72% (DK), 53% (L) and 51% (T) had an HbA1c <8% (p<0.05) and less than 50% of all groups had a total-cholesterol <5.0 mmol/l. In 39% (DK), 35% (L) and 37% (T) of the patients, no examination for retinopathy was registered during the period of 2000-2003. A cardiovascular diagnosis was registered in 27% (DK), 32% (L) and 33% (T) of the patients (p=NS).
CONCLUSION: Compared to native Danes, Lebanese and Turkish immigrants had a much higher prevalence of Type 2 diabetes and worse glycaemic regulation. The routine monitoring of diabetes care for native Danes, Lebanese or Turkish immigrants were similar. Overall, diabetes care is not satisfactory neither for native Danes, nor Lebanese or Turkish immigrants.

Entities:  

Mesh:

Year:  2007        PMID: 18632038     DOI: 10.1016/j.pcd.2007.07.007

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  15 in total

1.  Do immigrants from Turkey, Pakistan and Ex-Yugoslavia with newly diagnosed type 2 diabetes initiate recommended statin therapy to the same extent as Danish-born residents? A nationwide register study.

Authors:  Diana C Sanchez-Ramirez; Allan Krasnik; Helle Wallach Kildemoes
Journal:  Eur J Clin Pharmacol       Date:  2012-05-31       Impact factor: 2.953

Review 2.  Morbidity, Self-Perceived Health and Mortality Among non-Western Immigrants and Their Descendants in Denmark in a Life Phase Perspective.

Authors:  Signe Smith Jervelund; Sanam Malik; Nanna Ahlmark; Sarah Fredsted Villadsen; Annemette Nielsen; Kathrine Vitus
Journal:  J Immigr Minor Health       Date:  2017-04

Review 3.  Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis.

Authors:  Karlijn A C Meeks; Deivisson Freitas-Da-Silva; Adebowale Adeyemo; Erik J A J Beune; Pietro A Modesti; Karien Stronks; Mohammad H Zafarmand; Charles Agyemang
Journal:  Intern Emerg Med       Date:  2015-09-14       Impact factor: 3.397

Review 4.  Diabetes in migrants and ethnic minorities in a changing World.

Authors:  Luca Montesi; Maria Turchese Caletti; Giulio Marchesini
Journal:  World J Diabetes       Date:  2016-02-10

5.  Ethnic differences in diabetes-related mortality in the Brussels-Capital Region (2001-05): the role of socioeconomic position.

Authors:  Hadewijch Vandenheede; Lies Lammens; Patrick Deboosere; Sylvie Gadeyne; Myriam De Spiegelaere
Journal:  Int J Public Health       Date:  2011-02-08       Impact factor: 3.380

Review 6.  The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature.

Authors:  Trine Lignell Guldberg; Torsten Lauritzen; Jette Kolding Kristensen; Peter Vedsted
Journal:  BMC Fam Pract       Date:  2009-05-06       Impact factor: 2.497

7.  Migrant mortality from diabetes mellitus across Europe: the importance of socio-economic change.

Authors:  Hadewijch Vandenheede; Patrick Deboosere; Irina Stirbu; Charles O Agyemang; Seeromanie Harding; Knud Juel; Snorri Björn Rafnsson; Enrique Regidor; Grégoire Rey; Michael Rosato; Johan P Mackenbach; Anton E Kunst
Journal:  Eur J Epidemiol       Date:  2011-12-14       Impact factor: 8.082

8.  A combined analysis of 48 type 2 diabetes genetic risk variants shows no discriminative value to predict time to first prescription of a glucose lowering drug in Danish patients with screen detected type 2 diabetes.

Authors:  Malene Hornbak; Kristine Højgaard Allin; Majken Linnemann Jensen; Cathrine Juel Lau; Daniel Witte; Marit Eika Jørgensen; Annelli Sandbæk; Torsten Lauritzen; Åsa Andersson; Oluf Pedersen; Torben Hansen
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

9.  Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.

Authors:  R K Simmons; A H Carlsen; S J Griffin; M Charles; J S Christiansen; K Borch-Johnsen; A Sandbaek; T Lauritzen
Journal:  Diabet Med       Date:  2014-09-29       Impact factor: 4.359

10.  Quality of diabetes care for immigrants in the U.S.

Authors:  Florence J Dallo; Fernando A Wilson; Jim P Stimpson
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.